Literature DB >> 20957386

Decreased retinal nerve fiber layer thickness in patients with obstructive sleep apnea/hypopnea syndrome.

Pei-Wen Lin1, Michael Friedman, Hsin-Ching Lin, Hsueh-Wen Chang, Tanya M Pulver, Chien-Hung Chin.   

Abstract

BACKGROUND: To compare parameters for retinal nerve fiber layer (RNFL) thickness, optic nerve head (ONH) measurements, and macular thickness in patients with different severities of obstructive sleep apnea/hypopnea syndrome (OSAHS) versus normal controls.
METHODS: Patients presenting with snoring and daytime sleepiness who underwent overnight polysomnography to determine OSAHS severity were recruited, and subsequently referred for ophthalmologic evaluation. Optical coherence tomography was used to evaluate the retinal nerve fiber layer (RNFL), optic nerve head topography, and macular thickness for early detection of glaucoma. Patients determined not to have OSAHS were included as controls.
RESULTS: A total of 127 subjects were recruited, including 105 patients with OSAHS and 22 normal control subjects. RNFL thickness was significantly lower for the severe OSAHS group than for the control and mild OSAHS groups in the average (p < 0.0001) and in the superior quadrant (p = 0.0007). When subjects without OSAHS or with mild disease (AHI < 15) were grouped together and compared with patients with moderate/severe OSAHS (AHI ≧ 15), RNFL thickness measurements for the latter group were significantly lower in the average (p < 0.0001), and in the superior (p = 0.001), inferior (p = 0.029), and temporal (p = 0.007) quadrants. Positive correlations were identified between lowest oxygenation saturation on PSG and RNFL thickness in the average (r = 0.260), superior (r = 0.200) and nasal (r = 0.156) quadrants.
CONCLUSIONS: Compared to patients without OSAHS or those with mild disease, RNFL thickness was lower in patients with moderate/severe OSAHS. Lowest saturation of oxygen in the moderate/severe OSAHS group correlated with decreased RNFL thickness. Patients with moderate and severe OSAHS are at increased risk for glaucoma.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20957386     DOI: 10.1007/s00417-010-1544-1

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  35 in total

Review 1.  Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. The Report of an American Academy of Sleep Medicine Task Force.

Authors: 
Journal:  Sleep       Date:  1999-08-01       Impact factor: 5.849

Review 2.  Obstructive sleep apnea and related disorders.

Authors:  R D Chervin; C Guilleminault
Journal:  Neurol Clin       Date:  1996-08       Impact factor: 3.806

Review 3.  Practice parameters for the indications for polysomnography and related procedures: an update for 2005.

Authors:  Clete A Kushida; Michael R Littner; Timothy Morgenthaler; Cathy A Alessi; Dennis Bailey; Jack Coleman; Leah Friedman; Max Hirshkowitz; Sheldon Kapen; Milton Kramer; Teofilo Lee-Chiong; Daniel L Loube; Judith Owens; Jeffrey P Pancer; Merrill Wise
Journal:  Sleep       Date:  2005-04       Impact factor: 5.849

4.  Number of ganglion cells in glaucoma eyes compared with threshold visual field tests in the same persons.

Authors:  L A Kerrigan-Baumrind; H A Quigley; M E Pease; D F Kerrigan; R S Mitchell
Journal:  Invest Ophthalmol Vis Sci       Date:  2000-03       Impact factor: 4.799

5.  High prevalence of glaucoma in patients with sleep apnea syndrome.

Authors:  D S Mojon; C W Hess; D Goldblum; J Fleischhauer; F Koerner; C Bassetti; J Mathis
Journal:  Ophthalmology       Date:  1999-05       Impact factor: 12.079

6.  [Nocturnal measurements of intraocular pressure in patients with normal-tension glaucoma and sleep apnea syndrome].

Authors:  D Goldblum; J Mathis; M Böhnke; C Bassetti; C W Hess; M Gugger; D S Mojon
Journal:  Klin Monbl Augenheilkd       Date:  2000-05       Impact factor: 0.700

7.  Prevalence of glaucoma in patients with obstructive sleep apnoea--a cross-sectional case-series.

Authors:  R E Bendel; J Kaplan; M Heckman; P A Fredrickson; S-C Lin
Journal:  Eye (Lond)       Date:  2007-05-04       Impact factor: 3.775

8.  Regional differences in the structure of the lamina cribrosa and their relation to glaucomatous optic nerve damage.

Authors:  H A Quigley; E M Addicks
Journal:  Arch Ophthalmol       Date:  1981-01

9.  Clinically detectable nerve fiber atrophy precedes the onset of glaucomatous field loss.

Authors:  A Sommer; J Katz; H A Quigley; N R Miller; A L Robin; R C Richter; K A Witt
Journal:  Arch Ophthalmol       Date:  1991-01

10.  The prevalence of glaucoma in patients with sleep apnea syndrome: same as in the general population.

Authors:  Orna Geyer; Nahum Cohen; Eitan Segev; Eitan Z Rath; Lina Melamud; Ron Peled; Peretz Lavie
Journal:  Am J Ophthalmol       Date:  2003-12       Impact factor: 5.258

View more
  41 in total

1.  Reduction in retinal nerve fiber layer thickness in young adults with autism spectrum disorders.

Authors:  Leonardo Emberti Gialloreti; Matteo Pardini; Francesca Benassi; Sara Marciano; Mario Amore; Maria Giulia Mutolo; Maria Cristina Porfirio; Paolo Curatolo
Journal:  J Autism Dev Disord       Date:  2014-04

Review 2.  Obstructive sleep apnea-hypopnea syndrome (OSAHS) and glaucomatous optic neuropathy.

Authors:  Consuelo Pérez-Rico; Esperanza Gutiérrez-Díaz; Enrique Mencía-Gutiérrez; María Josefa Díaz-de-Atauri; Román Blanco
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-05-25       Impact factor: 3.117

3.  Evaluation of the visual function in obstructive sleep apnea syndrome patients and normal-tension glaucoma by means of the multifocal visual evoked potentials.

Authors:  Esperanza Gutiérrez-Díaz; Consuelo Pérez-Rico; María Josefa Díaz de Atauri; Enrique Mencía-Gutiérrez; Román Blanco
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-11-06       Impact factor: 3.117

4.  Retinal and optic nerve evaluation by optical coherence tomography in adults with obstructive sleep apnea-hypopnea syndrome (OSAHS).

Authors:  Paula Casas; Francisco J Ascaso; Eugenio Vicente; Gloria Tejero-Garcés; María I Adiego; José A Cristóbal
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-02-03       Impact factor: 3.117

5.  [Importance of perimetric differential diagnostics in patients with primary open-angle glaucoma].

Authors:  C Erb; K Göbel
Journal:  Ophthalmologe       Date:  2013-02       Impact factor: 1.059

6.  Correlation between structural progression in glaucoma and obstructive sleep apnea.

Authors:  Yuan-Yao Fan; Wei-Wen Su; Chun-Hsiu Liu; Henry Shen-Lih Chen; Shiu-Chen Wu; Shirley H L Chang; Kuan-Jen Chen; Wei-Chi Wu; Ning-Hung Chen; Hsueh-Yu Li; Ming-Hui Sun
Journal:  Eye (Lond)       Date:  2019-04-10       Impact factor: 3.775

7.  Peripapillary retina nerve fiber layer thickness and macular ganglion cell layer thickness in patients with obstructive sleep apnea syndrome.

Authors:  N Kara; N Sayin; S E Bayramoglu; A U Savas
Journal:  Eye (Lond)       Date:  2017-12-22       Impact factor: 3.775

8.  Evaluation of choroidal thickness in children with adenoid hypertrophy.

Authors:  Taliye Cakabay; Selin Üstün Bezgin; Sadık Etka Bayramoglu; Nihat Sayin; Murat Kocyigit
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-01-08       Impact factor: 2.503

9.  Evaluation of effects of positive airway pressure treatment on retinal fiber thickness and visual pathways using optic coherence tomography and visual evoked potentials in the patients with severe obstructive sleep apnea syndrome.

Authors:  Melike Batum; Ayşın Kısabay; Hüseyin Mayalı; Tuğba Göktalay; Emin Kurt; Deniz Selçuki; Hikmet Yılmaz
Journal:  Int Ophthalmol       Date:  2020-06-06       Impact factor: 2.031

10.  Ganglion cell layer thickening in patients suffering from Obstructive Sleep Apnea-Hypopnea syndrome with long Mean Apnea-Hypopnea Duration during sleep.

Authors:  Evangelia Chalkiadaki; Konstantinos Andreanos; Efthymios Karmiris; Chrysoula Florou; Xanthi Tsiafaki; Anastasia Amfilochiou; Ilias Georgalas; Chrysanthi Koutsandrea; Dimitrios Papaconstantinou
Journal:  Int Ophthalmol       Date:  2020-11-17       Impact factor: 2.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.